###begin article-title 0
Multiple gene polymorphisms analysis revealed a different profile of genetic polymorphisms of primary open-angle glaucoma in northern Chinese
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 91 91 91 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
To evaluate the individual and interactive effects of polymorphisms in the myocilin (MYOC),optineurin (OPTN), WD repeat domain 36 (WDR36), and apolipoprotein E (APOE) genes on primary open-angle glaucoma (POAG) in northern Chinese.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 427 428 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Northern Chinese study subjects, 176 POAG patients and 200 controls, were recruited for screening of the coding exons and splicing regions of MYOC. Five single nucleotide polymorphisms (SNPs) in OPTN (M98K, R545Q, IVS5+38T>G, IVS8-53T>C, and IVS15+10G>A), one SNP in WDR36 (IVS5+30C>T) as well as the APOE promoter and epsilon2/epsilon3/epsilon4 polymorphisms were also examined. Association analysis was performed by using chi2 analysis. High-order gene-gene interaction was also analyzed using the multifactor dimensionality reduction (MDR) method.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 3 7 3 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 227 233 227 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> WDR36</italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 325 329 325 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 338 339 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 338 339 338 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 357 361 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 370 371 370 371 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
###xml 374 378 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 387 388 387 388 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 405 406 405 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
###xml 413 417 413 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 423 424 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 423 424 423 424 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
In MYOC, 22 variants were identified. Four of them were novel but found in controls only. The missense mutation, Val53Ala, is likely a glaucoma causing mutation, accounting for 0.6% of cases. No individual polymorphism in OPTN, WDR36, or APOE was associated with POAG. MDR analysis identified a best 6-factor model for POAG: MYOC IVS2+35A>G, OPTN Met98Lys, OPTN IVS5+38T>G, OPTN IVS8-53T>C, WDR36 IVS5+30C>T, and APOE -491A>T.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> OPTN</italic>
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
The association pattern between the genes, MYOC, OPTN, WDR36, and APOE, and POAG in northern Chinese is different from that of southern Chinese. Disease-causing mutations in MYOC accounted for a small proportion of northern Chinese POAG patients. Common polymorphisms in these genes were not associated with POAG individually but might interactively contribute to the disorder, supporting a polygenic etiology.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 252 258 <span type="species:ncbi:9606">people</span>
Glaucoma is a heterogeneous group of optic neuropathies characterized by progressive degeneration of the optic nerve that leads to irreversible loss of vision. It is the second leading cause of blindness worldwide, estimated to affect about 70 million people [1]. Primary open-angle glaucoma (POAG, OMIM ) is the major type of primary glaucoma in most populations. It is evidenced as a complex disorder with multiple risk factors, and genetic factors may play an important role in the etiology of this disorder.
###end p 11
###begin p 12
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 176 180 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 190 191 190 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 221 226 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 995 997 995 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1017 1021 1017 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1055 1059 1055 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1207 1211 1207 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1314 1316 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 1317 1319 1317 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
So far, at least 22 genetic loci had been linked to POAG [2-4], and three genes have been identified for POAG from the reported loci, myocilin (MYOC, OMIM ) [5,6], optineurin (OPTN, OMIM ) [7,8], and WD repeat-domain 36 (WDR36, OMIM ) [9]. However, mutations in these three genes account for less than 10% of POAG cases. Therefore, it had been assumed that only a portion of POAG follows the classical Mendelian inheritance while others are caused by variants in several genes, each of which contributes minor effects to disease onset and pathogenesis [10-12]. Presumably, many different genes, each with allelic variations, contribute to the observed variability in a trait, with no particular gene having a single dominant effect [13]. It is likely that single nucleotide polymorphisms (SNPs) in a single gene contributes only a small effect to disease [14] while some genetic variations do not cause diseases individually but act through interaction with other genes. Recently, Park's study [15] had revealed that OPTN could regulate the expression of MYOC primarily through the control of mRNA stability, indicating that interaction exists between the two glaucoma genes. In addition, apolipoprotein E (APOE; OMIM ) has also been reported to be a potent modifier gene and may interactively contribute to POAG [10,11]. These findings provided evidence for the multigenic characteristics of POAG.
###end p 12
###begin p 13
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 432 438 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> WDR36</italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
To date, the reported findings on glaucoma genetics in Chinese are mostly based on southern Chinese of Hong Kong [2-4,11,16,17], while relevant genetic information from the northern Chinese was limited. Recently, however, a genomic analysis revealed that the genetic ancestries of Chinese can be divided into a southern and a northern group [18]. Therefore, in this present study, we evaluated the genetic association of MYOC, OPTN, WDR36, and APOE polymorphisms with POAG in a group of northern Chinese. The distribution patterns of the gene variants between the northern and southern Han populations were also compared to discern whether any differential distributions of gene variants exist.
###end p 13
###begin p 14
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
Moreover, possible gene-gene interactions among the variants in these genes were also evaluated. Statistically, for gene-gene interaction analysis, logistic regression (LR) is a commonly used method in case-control studies. However, it had been suggested that LR is less powerful if individual variables did not have significant main effects. Only variables that contain an independent main effect will be included in the final model [19]. Moreover, LR is less suitable for a large number of polymorphisms as more analyzed parameters may lead to higher likelihood of false positive and false negative results [20]. In contrast, multifactor dimensionality reduction (MDR) is a nonparametric method, which is less problematic in dimensionality, and is useful for analyzing the interactions among a large number of polymorphisms [20-23]. Therefore, LR was used to analyze the pairwise gene-gene interaction if any two gene variants are found to have significant main effects on POAG. Otherwise, MDR was applied to explore the high-order gene-gene interaction that may be involved in the genetic architecture of POAG in the northern Chinese population.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Case and control study subjects
###end title 16
###begin p 17
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 15 23 <span type="species:ncbi:9606">patients</span>
###xml 893 899 <span type="species:ncbi:9606">people</span>
Unrelated POAG patients and control subjects were recruited from the Eye Center of Beijing Tongren Hospital (Beijing, China). All the subjects are Han Chinese. They came from Beijing or nearby areas, representing a northern Chinese group. Diagnosis of POAG was based on exclusion of congenital glaucoma and secondary causes (trauma, uveitis, or steroid-induced glaucoma), anterior chamber angle open (grade III or IV gonioscopy), optic disc changes (vertical cup-to-disc ratio greater than 0.5, disc hemorrhage, or thin or notched neuroretinal rim), and visual field changes according to Anderson's criteria [24]. Visual acuity was determined by the Snellen eye chart, intraocular pressure (IOP) by applanation tonometry, and visual field by a perimeter (Humphrey Field Analyzer; Carl Zeiss Meditec, Dublin, CA) with the Glaucoma Hemifield test. Unrelated control subjects were recruited from people attending the Tongren Eye Center for conditions such as senile cataract, floaters, and itchy eyes. They were given the same ophthalmic examinations and were diagnosed not to have glaucoma or other major eye diseases.
###end p 17
###begin p 18
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 684 689 <span type="species:ncbi:9606">Human</span>
In our study, we included subjects with juvenile onset open-angle glaucoma (JOAG) and adult onset POAG. Totally, there were 176 sporadic patients with POAG, 138 males and 38 females, with age at diagnosis ranging from 10 to 82 years (mean+/-SD: 38.92+/-16.33) and with the highest recorded IOP before treatment being higher than 21 mmHg. We included control subjects aged 60 or above as they are less likely to develop POAG later in their lives. There were 200 control subjects, 150 males and 50 females, with age ranging from 61 to 85 years (mean+/-SD: 69.41+/-5.97) and with the highest recorded IOP of less than 18 mmHg. The study protocol was approved by the Ethics Committee for Human Research of Tongren Hospital and Capital Medical University (Beijing, China) and adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all study subjects after explanation of the nature and possible consequences of the study. Venous blood was obtained from the subjects and stored at -20 degreesC for less than two months before DNA extraction.
###end p 18
###begin title 19
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> WDR36</italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
Analysis of the MYOC sequences and single nucleotide polymorphisms in OPTN, WDR36, and APOE
###end title 19
###begin p 20
###xml 163 167 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 218 222 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 478 480 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
Genomic DNA was extracted from 200 mul of whole blood using a QIAmp Blood Kit (Qiagen, Hilden, Germany). To detect any possible novel disease-causing mutations in MYOC, the three coding exons and adjacent sequences of MYOC were screened by polymerase chain reaction (PCR) followed by direct DNA sequencing with a BigDye Terminator DNA sequencing kit on a 3130XL analyzer (Applied Biosystems, Foster City, CA), using the same set of primers that were used in our previous study [17].
###end p 20
###begin p 21
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 574 575 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 584 589 584 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 933 937 933 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1444 1446 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
As for the other three genes, only polymorphisms that might be informative in POAG genetics were selected for this study. If any significant association was detected, further fine mapping or re-sequencing of that gene will be performed. Accordingly, five SNPs in OPTN (c.603T>A [M98K], c.1944G>A [R545Q], IVS5+38T>G, IVS8-53T>C, and IVS15+10G>A) were selected, as they had been found to have statistical association with POAG or have interaction with other variants of the disease. They were genotyped by direct sequencing according to the protocol of our previous studies [3,16]. In WDR36, IVS5+30C>T had been found to be significantly associated with POAG in Hong Kong Chinese (unpublished data), and therefore was investigated by direct DNA sequencing, using the same pair of primers (primer for the forward strand: 5'-TAG ATT AGT ATC TAA GTC TGT GG-3' and primer for the reverse strand: 5'-TGT TAT TTA TAG ACA ACC CTC CA-3'). In APOE, the promoter polymorphisms (-491A>T, -427T>C, and -219T>G) and the epsilon2/epsilon3/epsilon4 polymorphisms in exon 4 (c.526C>T for epsilon2 and c.388T>C for epsilon4) were investigated by the TaqMan genotyping assays in an ABI Prism 7000 Sequence Detection System (Applied Biosystems) according to the manufacturer's instructions. The accuracy of genotyping with TaqMan was evaluated by direct sequencing in about one quarter of randomly selected samples according to the protocol of our previous study [11]. Complete matching of results was obtained.
###end p 21
###begin title 22
Statistical analysis
###end title 22
###begin p 23
###xml 76 77 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 169 170 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
Hardy-Weinberg equilibrium (HWE) was tested for each polymorphism by the chi2 test. Allele or genotype frequencies between patients and controls were compared by the chi2 test or Fisher's exact test. Significant levels for multiple comparisons were corrected by the Bonferroni method. SPSS version15.0 software (SPSS Inc., Chicago, IL) was used.
###end p 23
###begin p 24
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
Pairwise linkage disequilibrium (LD) estimation and expectation-maximization (EM)-based haplotype association analysis were performed for the variants in MYOC, OPTN, and APOE, respectively, using  [25].
###end p 24
###begin p 25
LR analysis was used for gene-gene interactions only if the variants were detected to have significant main effects. The disease status was set as the dependent variable (POAG=1, control=0) and gene polymorphisms as the independent variables (homozygote=2, heterozygote=1, wild type=0). The LR model was built with parameters for the independent effects of both variants. If significant interaction was detected, stratified analysis will be used to verify the gene-gene interactions. The study subjects will be stratified according to the genotype of one gene followed by the analysis of another gene in a different stratum defined by the genotype of the former gene. Homogeneity of the odds ratios (ORs) in different strata will be tested by the Breslow-Day test.
###end p 25
###begin p 26
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
High order gene-gene interaction models among all the polymorphisms in the four candidate genes were detected and characterized using the multifactor dimensionality reduction (MDR) method as proposed by Ritchie et al. [23]. A detailed explanation on the MDR method has been described elsewhere [23,26,27]. Among the set of best multifactor models, the combination of genetic factors that maximizes the testing accuracy and/or the highest cross-validation consistency (CVC) is selected and further evaluated using permutation testing. p values associated with each prediction error and cross-validation consistency were determined by the Sign Test (a nonparametric test implemented in the MDR software) and corrected by a permutation test. For the best model, the interaction dendrogram, which was generated by MDR, was used to confirm, visualize, and interpret the interaction model. The MDR analysis was performed by using the open-source MDR software package (version 1.0.0, freely available online at ).
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
Univariate analysis of individual polymorphisms in MYOC
###end title 28
###begin p 29
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 76 83 76 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 539 547 <span type="species:ncbi:9606">patients</span>
###xml 578 585 <span type="species:ncbi:9606">patient</span>
The allele and genotype frequencies of the MYOC variants were summarized in Table 1. In total, 22 polymorphisms had been identified. All of them followed HWE. Association analysis showed that none of these polymorphisms was statistically associated with POAG (p>0.0023, Bonferroni corrected significance level). Four variants (Gln161Arg, Gly183Ser, IVS1+16G>T, and Asn428Ser) were novel. They were detected in controls only. In contrast, variants Gly12Arg, Val53Ala, and Thr353Ile were found only in POAG cases with Gly12Arg in three POAG patients and the other two each in one patient. All were heterozygous. According to Alward's criteria [28], they were likely disease-causing mutations (DCMs).
###end p 29
###begin title 30
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
MYOC polymorphisms identified in this study.
###end title 30
###begin p 31
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
MYOC polymorphisms identified by direct DNA sequencing in this study were shown it the table. The asterisk indicates that the change is a disease-causing mutation and was found in POAG patients. The 'hyphen' represents non-coding variation. The numbers under "Genotype frequency" are the counts of homozygotes, heterozygotes, and wild type.
###end p 31
###begin title 32
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
Distribution of single nucleotide polymorphisms in OPTN and WDR36
###end title 32
###begin p 33
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 313 320 313 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
Genotypic frequencies of OPTN (Met98Lys, Arg545Gln, IVS5+38T>G, IVS8-53T>C, and IVS15+10G>A) and WDR36 (IVS5+30C>T) followed HWE in cases and controls. No significant difference was detected between POAG cases and controls in the genotypic or allelic frequencies (Bonferroni corrected significance level, p>0.01; Table 2).
###end p 33
###begin title 34
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
OPTN and WDR36 polymorphisms investigated in the present study.
###end title 34
###begin p 35
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
Allelic and genotypic frequencies of the five candidate SNPs in the present study were shown in the table. As only one WDR36 SNP was selected, this SNP was also presented in this table. The "-" represents non-coding polymorphism. The numbers under "Genotype frequency" are the counts of homozygotes, heterozygotes, and wildtype.
###end p 35
###begin title 36
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
Univariate analysis of individual polymorphisms in APOE
###end title 36
###begin p 37
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 52 53 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 52 53 52 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 70 71 70 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
###xml 323 330 305 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
Genotypes of all the APOE polymorphisms, i.e., -491A>T, -427T>C, -219T>G, and the epsilon2/epsilon3/epsilon4 polymorphism, followed the HWE in both study groups. Their genotypic or allelic distributions were not statistically different between POAG patients and controls (p>0.0125, Bonferroni corrected significance level, Table 3).
###end p 37
###begin title 38
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
APOE polymorphisms investigated in the present study.
###end title 38
###begin p 39
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
Allelic and genotypic frequencies of the four APOE polymorphisms in case and control subjects were shown in the table. None of them was significantly associated with POAG.
###end p 39
###begin title 40
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
Haplotype association analysis for the variants in MYOC, OPTN, and APOE
###end title 40
###begin p 41
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
For MYOC, LD analysis revealed one LD block, spanning from the promoter (-83G>A) to exon 1 (c.227G>A). Within this block, polymorphisms -83G>A and c.227G>A were the only two variants that had a minor allele frequency (MAF) greater than 1%. They were in strong LD (D'=0.974). The haplotype G-G, defined by the major alleles of these two SNPs, presented in 95.5% of cases and 92.2% of controls. It was not statistically associated with POAG. The minor haplotype A-A was not associated with glaucoma. IVS2+35A>G was the only other MYOC polymorphism that had a MAF greater than 1%. When it was included in haplotype analysis, none of the haplotypes, which were defined by the three SNPs, showed any significant association with POAG (data not shown).
###end p 41
###begin p 42
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
For OPTN, only five common variants were genotyped, and no LD block was detected. We had tried every possible combination of these five SNPs to evaluate haplotype association but found no haplotype significantly associated with glaucoma (data not shown).
###end p 42
###begin p 43
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 263 264 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 263 264 245 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
###xml 272 273 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 272 273 254 255 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
###xml 285 286 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&gt;</italic>
###xml 285 286 267 268 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>&gt;</italic></bold>
For APOE, only the three promoter SNPs and the epsilon2/epsilon3/epsilon4 polymorphism in exon 4 were genotyped, and no LD block was detected. Haplotype analysis showed that the common haplotypes (frequency>5%), which are defined by the three promoter SNPs (-491A>T, -427T>C, and -219T>G), were not associated with POAG. When the epsilon2/epsilon3/epsilon4 polymorphisms (c.526C>T and c.388T>C) were included in haplotype analysis, no common haplotype was found to be significantly associated with glaucoma.
###end p 43
###begin title 44
Gene-gene interaction analysis
###end title 44
###begin p 45
###xml 189 196 189 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 648 656 648 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 765 770 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 785 789 785 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 806 810 806 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 990 994 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1012 1016 1012 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1090 1094 1090 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
Since we found no variant having strong significant association with POAG, we did not use logistic regression to build the interaction model. By using MDR analysis, six models were formed (Table 4), a best model that included six SNPs from all four genes was identified, including IVS2+35 A>G in MYOC; Met98Lys, IVS5+38T>G, and IVS8-53T>C in OPTN; IVS5+30C>T in WDR36; and -491A>T in APOE. The combination of these possibly interactive polymorphisms in the model gave a maximum CVC of 10/10 and a maximum testing accuracy of 0.5514. The p value associated with the prediction error and CVC was 0.0107 (p<0.001 after corrected by permutation test). Figure 1 illustrates the interaction dendrogram for this model. The hierarchical cluster analysis placed IVS5+30C>T (WDR36), IVS8-53T>C (OPTN), and Met98Lys (OPTN) on the same branch, and their closer position in the diagram clearly showed that the three SNPs may have a synergistic interaction effect on modulating risk of POAG. IVS5+38T>G (OPTN) and IVS2+35A>G (MYOC) were on another branch, revealing an interaction between them. -491A>T (APOE) was located on a different remote branch, suggesting that this SNP may have less of a relationship with other SNPs.
###end p 45
###begin title 46
Multi-locus interactions by the multifactor dimensionality reduction approach.
###end title 46
###begin p 47
Interaction models with one to six factors generated by the MDR program were shown in the table. The six-factor model with highest CVC (10/10) and maximum testing accuracy (55.14%) was selected as the best model in this study. The asterisk indicates that as the sample numbers in cases and controls are dissimilar in this study, the T value, which is the threshold ratio used to distinguish high-risk genotype combinations from low risk genotype combinations, was set to 0.88 (number of cases/number of controls, i.e., 176/200) while running the MDR program. CVC: cross-validation consistency.
###end p 47
###begin p 48
Interaction dendrogram for the six polymorphisms modeled by MDR. The colors comprise a spectrum representing a continuum from synergy to redundancy. The red color represents a high degree of synergy (positive information gain), orange a lesser degree, and gold represents the midway point between synergy and redundancy. On the redundancy end of the spectrum (not appeared in our model), the highest degree is represented by the blue color with a lesser degree represented by green.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 126 130 126 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 300 307 300 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 593 594 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 1237 1238 1237 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 1239 1241 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 1620 1622 1620 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 2036 2038 2036 2038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 2191 2198 2191 2198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
###xml 861 869 <span type="species:ncbi:9606">patients</span>
###xml 1314 1322 <span type="species:ncbi:9606">patients</span>
For the first time, we have investigated the association between multiple genes and POAG in a northern Chinese population. In MYOC, we have detected four novel variants, Gln161Arg, Gly183Ser, IVS1+16G>T, and Asn428Ser, each in one control subject, but these variants were not found in POAG patients (Table 1). From published reports, MYOC mutations have been attributed to about 1%-4% of POAG cases, and this rate can be as high as 36% in JOAG families [29]. In the Chinese population of Hong Kong, which is southern Chinese, the prevalence of MYOC mutations is about 1.1%-1.8% in POAG cases [2]. In this present study, the non-synonymous polymorphisms, Gly12Arg, Val53Ala, and Thr353Ile, were found only in POAG cases but not in controls. According to Alward's criteria [28], they were likely DCMs for POAG. However, a previous study on Hong Kong Chinese POAG patients showed that the Gly12Arg and Thr353Ile variants were not disease-causing; each of them was detected in four control subjects (0.7%) [11]. Therefore, the remaining Val53Ala variant might be the only DCM for POAG in the northern Chinese group, accounting for only 0.6% of POAG cases. Such a mutation rate is lower than that reported in Caucasians and southern Chinese [2,29]. However, since the Gly12Arg variant was detected in 3 of the 176 POAG patients but none of the 200 healthy controls, we could not rule out its possibility of being a POAG-related variant in ethnic northern Chinese. A larger sample size is required to confirm its role on POAG. In addition, we found Gln19His in one control subject, which was previously suggested to be a DCM [11]. This subject was a 69-year-old female with normal fundus. She did not have a family history of glaucoma. Therefore, the Gln19His variant is unlikely a disease-causing mutation for POAG in northern Chinese. Apart from the rare variants, the three common polymorphisms (MAF>1%), -83G>A, R76K, and IVS2+35A>G, were not statistically associated with POAG, consistent with findings in southern Chinese in Hong Kong [11]. The allelic frequencies of these SNPs were also found to be similar between the northern Chinese of this study and the southern Chinese of Hong Kong (Table 5).
###end p 50
###begin title 51
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
Allele frequencies of MYOC, OPTN, and APOE variants in southern and northern Chinese.
###end title 51
###begin p 52
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 454 455 452 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Allelic frequencies of MYOC, OPTN, and APOE polymorphisms were compared between southern and northern Chinese. The asterisk indicates that the genetic data of the southern Chinese referred to our previous publication [11. In MYOC, only the three common SNPs (MAF>1%) were shown in the table, and only the frequencies of the minor allele of each polymorphism were shown in the table. The allelic frequencies of the polymorphisms were compared with the chi2 test. The p values were corrected by the Bonferroni method (p<0.05/13=0.0038 was considered statistically significant).
###end p 52
###begin p 53
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 562 566 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 710 714 710 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 760 767 760 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 931 932 929 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1058 1060 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 1671 1672 1667 1668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1688 1691 1684 1687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 1709 1710 1703 1704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1726 1729 1720 1723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;26</sup>
###xml 1910 1917 1904 1911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 1980 1984 1974 1978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 2097 2104 2091 2098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 2441 2445 2435 2439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 2450 2454 2444 2448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
OPTN mutations had been reported to account for 1%-1.6% of sporadic Chinese POAG patients [11,16]. However, later studies reported no glaucoma causing mutations in OPTN among Caucasian and Japanese POAG patients [30-32]. In this study, the five SNPs that were selected to be genotyped had been reported to be either associated with POAG individually or act interactively with other genes on the disease [11,16]. After univariate analysis, none of them showed significant association with glaucoma. However, we found that the allelic distribution of the selected OPTN variants among this present study population was different from the southern Chinese population [11]. The allelic frequencies of the genotyped OPTN variants in the two populations are shown in Table 5. The exonic SNP, Met98Lys, presented a bit lower in the northern Chinese than that in the southern Chinese, but the difference was not statistically different (chi2=2.6, p>0.1 when comparing the allelic frequencies of this variant in the control group in the two studies, 12% versus 15.7% [11]). Another exonic variant, Arg545Gln, and the intronic variant, IVS15+10G>A, also showed comparable allelic distributions among the two Chinese populations. However, IVS5+38T>G, which was significantly associated with POAG in the southern Chinese, was found to be distributed drastically differently between the two populations. It occurred in 12.4% POAG and 5.2% controls in the southern Chinese. In contrast, in the northern Chinese, this SNP was detected in 33.5% of cases and 30.25% of controls, significantly higher than that in the southern Chinese after adjustment for multiple comparison (in cases, chi2=60.59, p=7.0x10-15; in controls, chi2=111.8, p=4.0x10-26). Another intronic SNP, IVS8-53T>C, was also found to have higher allelic frequencies in the northern Chinese, although the p values became borderline after Bonferroni correction (Table 5). Such difference in allelic distributions was also found for APOE -427T>C, which presented at significantly higher frequencies in the northern Chinese than the southern Chinese (Table 5). Such discrepancies can probably be explained by the presence of ancestry-related differences in allele frequencies between the northern and southern Chinese. However, only five SNPs in each of the two genes were investigated in the present study. Our data might have revealed only part of a discrepancy in the distribution pattern of OPTN and APOE polymorphisms. A more thorough investigation of the sequences of these genes is warranted to enable a more comprehensive comparison.
###end p 53
###begin p 54
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 168 176 <span type="species:ncbi:9606">patients</span>
Recent studies suggested that WDR36 defects may contribute to the glaucomatous disease process as a glaucoma modifier gene [33,34]. In a group of southern Chinese POAG patients, only one SNP in WDR36, IVS5+30C>T, showed significant association with POAG, and it is a common polymorphism (unpublished data). However, this SNP did not showed significant association with glaucoma in this study on the northern Chinese.
###end p 54
###begin p 55
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> OPTN</italic>
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> WDR36</italic>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 986 990 986 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1039 1043 1039 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1174 1176 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 1213 1217 1213 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1238 1243 1238 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OLFM2</italic>
###xml 1374 1376 1374 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 1464 1468 1464 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1484 1488 1484 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1517 1521 1499 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1537 1541 1519 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1562 1566 1544 1548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1581 1585 1563 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1663 1667 1627 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1682 1686 1646 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1711 1715 1675 1679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1731 1735 1695 1699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1820 1824 1784 1788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1826 1830 1790 1794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1832 1837 1796 1801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 1843 1847 1807 1811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 2024 2028 1988 1992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 2119 2124 2083 2088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 2140 2144 2104 2108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 2212 2216 2176 2180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 2292 2296 2256 2260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 2312 2316 2276 2280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 2465 2469 2429 2433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 2851 2853 2815 2817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 1088 1096 <span type="species:ncbi:9606">patients</span>
###xml 1312 1320 <span type="species:ncbi:9606">patients</span>
Findings of this present study suggest that the roles of MYOC, OPTN, WDR36, and APOE on the genetic architecture of POAG are different among northern and southern Chinese. To date, although variations in a variety of genes had shown statistical associations with glaucoma, these associations were often not replicable in other populations. Some of these SNPs may be of functional significance, and their frequencies may vary significantly between different ethnic groups. For example, three DCMs at MYOC (Gly252Arg, Gly367Arg, and Pro370Leu) were found in Asians and Caucasians, and three (Thr293Lys, Thr377Met, and Glu352Lys) were found in Africans and Caucasians. No single mutation was shared by all three ethnic populations, suggesting most DCMs exist in a specific ethnicity [29]. It may also suggest that a single gene locus may not cause glaucoma but act interactively with other gene variants [20]. Evidence for this hypothesis has been reported. Ishikawa et al. [35] found the APOE promoter polymorphism, -491A>T, interacted with MYOC -1000C>G (MYOC.mt1) to increase IOP in POAG patients, but the individual effect of MYOC.mt1 is unclear. Further, Funayama et al. [12] found that common polymorphisms in OPTN and olfactomedin 2 (OLFM2) may interactively contribute to the development of OAG in Japanese patients. In the Chinese population of Hong Kong, Fan et al. [11] detected three pairs of statistical interactions for normal tension glaucoma (between MYOC -83G>A and the APOE epsilon2/epsilon3/epsilon4, MYOC IVS2+35A>G and APOE -219T>G, as well as OPTN Arg545Gln and APOE epsilon2/epsilon3/epsilon4)) and two pairs of interactions for POAG (between MYOC Thr353Ile and OPTN IVS15+10G>A and between OPTN IVS5+38T>G and APOE -491A>T). In this present study, a best interaction model involving six variants in MYOC, OPTN, WDR36, and APOE had been identified for POAG in a northern Chinese population by using MDR. This finding suggested that these genes might act in concert to modulate the risk of POAG, although MYOC attributed a more dominant effect. According to the interaction dendrogram, the variants, WDR36 IVS5+30C>T and OPTN IVS8-53T>C, are expected to have a strong synergistic interaction. OPTN Met98Lys has lesser synergistic interaction with both. Similarly, variants OPTN IVS5+38T>G and MYOC IVS2+35A>G also have strong synergistic interaction themselves but having lesser interaction with the three variants in the first branch. Moreover, APOE -491A>T may have the least degree of interaction with other variants. This dendrogram provided preliminary information about the interactive relationships among the variants in the model. However, one limitation of the MDR method is that it is difficult to evaluate the effects of each individual polymorphism in the models and to authenticate the combination of the risk alleles [36]. These issues still need to be addressed. Another limitation of this study is the lack of replication. As the interaction model detected in this study had not been identified in the southern Chinese or other populations, it should be evaluated in other Chinese populations.
###end p 55
###begin p 56
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 379 387 <span type="species:ncbi:9606">patients</span>
In conclusion, we have for the first time investigated the roles of polymorphisms in MYOC, OPTN, WDR36, and APOE in POAG in a group of northern Chinese. The distributions of some variants were drastically different from that in the general southern Chinese population. The possibly disease-causing mutations in MYOC accounted for only a small proportion of northern Chinese POAG patients. The common polymorphisms in the candidate genes were not significantly associated with glaucoma, although a larger sample of northern Chinese should be required to unravel their contributions to POAG if their effects are mild. However, some of the common polymorphisms in these genes might interactively contribute to POAG, supporting a polygenic etiology of this common and complex disease.
###end p 56
###begin title 57
Acknowledgments
###end title 57
###begin p 58
###xml 368 380 <span type="species:ncbi:9606">participants</span>
This work was supported in part by block grants from Mr. Lai Seung Hung and Mrs. Lai Chan Pui Ngong Fund, Hong Kong and Beijing Natural Science Foundation, 7081001, China, respectively, and by a direct grant, KM200610025025, from Scientific Research Common Program of Beijing Municipal Commission of Education of China. We express our greatest appreciation to all the participants in the study.
###end p 58
###begin title 59
References
###end title 59
###begin article-title 60
###xml 10 16 <span type="species:ncbi:9606">people</span>
Number of people with glaucoma worldwide.
###end article-title 60
###begin article-title 61
Gene mapping for primary open angle glaucoma.
###end article-title 61
###begin article-title 62
A genome-wide scan maps a novel juvenile-onset primary open angle glaucoma locus to chromosome 5q.
###end article-title 62
###begin article-title 63
A genome-wide scan maps a novel juvenile-onset primary open-angle glaucoma locus to 15q.
###end article-title 63
###begin article-title 64
Genetic linkage of familial open angle glaucoma to chromosome 1q21-q31.
###end article-title 64
###begin article-title 65
Identification of a gene that causes primary open angle glaucoma.
###end article-title 65
###begin article-title 66
Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
###end article-title 66
###begin article-title 67
Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region.
###end article-title 67
###begin article-title 68
Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.
###end article-title 68
###begin article-title 69
Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene.
###end article-title 69
###begin article-title 70
###xml 107 115 <span type="species:ncbi:9606">patients</span>
SNPs and interaction analyses of myocilin, optineurin, and apolipoprotein E in primary open angle glaucoma patients.
###end article-title 70
###begin article-title 71
###xml 86 94 <span type="species:ncbi:9606">patients</span>
SNPs and interaction analyses of noelin 2, myocilin, and optineurin genes in Japanese patients with open-angle glaucoma.
###end article-title 71
###begin article-title 72
A perspective on epistasis: limits of models displaying no main effect.
###end article-title 72
###begin article-title 73
Traversing the conceptual divide between biological and statistical epistasis: systems biology and a more modern synthesis.
###end article-title 73
###begin article-title 74
Interaction between two glaucoma genes, optineurin and myocilin.
###end article-title 74
###begin article-title 75
Different optineurin mutation pattern in primary open-angle glaucoma.
###end article-title 75
###begin article-title 76
TIGR/MYOC gene sequence alterations in individuals with and without primary open-angle glaucoma.
###end article-title 76
###begin article-title 77
###xml 10 15 <span type="species:ncbi:9606">human</span>
Worldwide human relationships inferred from genome-wide patterns of variation.
###end article-title 77
###begin article-title 78
A comparison of analytical methods for genetic association studies.
###end article-title 78
###begin article-title 79
Analysis of multiple SNPs in genetic association studies: comparison of three multi-locus methods to prioritize and select SNPs.
###end article-title 79
###begin article-title 80
###xml 113 118 <span type="species:ncbi:9606">human</span>
Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studies.
###end article-title 80
###begin article-title 81
Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity.
###end article-title 81
###begin article-title 82
Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies.
###end article-title 82
###begin article-title 83
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 83
###begin article-title 84
Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions.
###end article-title 84
###begin article-title 85
Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.
###end article-title 85
###begin article-title 86
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Variations in the myocilin gene in patients with open-angle glaucoma.
###end article-title 86
###begin article-title 87
dissection of myocilin glaucoma.
###end article-title 87
###begin article-title 88
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma.
###end article-title 88
###begin article-title 89
###xml 89 97 <span type="species:ncbi:9606">patients</span>
The association between Japanese primary open-angle glaucoma and normal tension glaucoma patients and the optineurin gene.
###end article-title 89
###begin article-title 90
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Lack of association of mutations in optineurin with disease in patients with adult-onset primary open-angle glaucoma.
###end article-title 90
###begin article-title 91
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma.
###end article-title 91
###begin article-title 92
The role of the WDR36 gene on chromosome 5q22.1 in a large family with primary open-angle glaucoma mapped to this region.
###end article-title 92
###begin article-title 93
Association between glaucoma and gene polymorphism of endothelin type A receptor.
###end article-title 93
###begin article-title 94
An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation.
###end article-title 94

